Biologic drugs induced vitiligo: case reports and review of literature

Biological drugs are extensively used to treat various inflammatory diseases, including psoriasis, atopic dermatitis (AD), and rheumatoid arthritis. While generally effective and safe, these therapies have been increasingly associated with secondary development of vitiligo, especially with anti-TNF...

Celý popis

Uložené v:

Podrobná bibliografia
Vydané v:	Frontiers in immunology Ročník 15; s. 1455050
Hlavní autori:	Shao, Xinyi, Chen, Tingqiao, Pan, Xingyu, Chen, Shuang, Chen, Yangmei, Chen, Jin
Médium:	Journal Article
Jazyk:	English
Vydavateľské údaje:	Switzerland Frontiers Media SA 17.12.2024 Frontiers Media S.A
Predmet:	Adolescent Aged, 80 and over Antibodies, Monoclonal, Humanized - adverse effects Antibodies, Monoclonal, Humanized - therapeutic use Atopic dermatitis Biological products Biological Products - adverse effects Biological Products - therapeutic use biological therapy Case reports Crohn's disease cytokine imbalance Dermatitis Dermatitis, Atopic - drug therapy Drug development Drug dosages dupilumab-induced vitiligo Erythema Female Females Fungal infections Helper cells Homeostasis Humans Immunology Inflammatory diseases inflammatory skin diseases Legs Literature reviews Lymphocytes T Male Patients Psoriasis Rheumatoid arthritis Steroids Tumor necrosis factor Vitiligo Vitiligo - chemically induced atopic dermatitis inflammatory skin diseases dupilumab-induced vitiligo biological therapy cytokine imbalance
ISSN:	1664-3224, 1664-3224
On-line prístup:	Získať plný text
Tagy:	Pridať tag Žiadne tagy, Buďte prvý, kto otaguje tento záznam!

Buďte prvý, kto okomentuje tento záznam!